SHOULDER & ELBOW
NSAID injection of ketorolac improved UCLA scores & passive abduction in patients with SIS
J Shoulder Elbow Surg. 2013 May;22(5):595-601. doi: 10.1016/j.jse.2012.08.026. Epub 2012 Nov 2248 patients with subacromial impingement syndrome (SIS) were randomized to receive a single subacromial injection of either the nonsteroidal anti-inflammatory drug (NSAID), ketorolac, or the corticosteroid, triamcinolone, in order to determine which of the two was more effective in improving shoulder pain and function. Following assessments over a 4 week period, patients who received the NSAID injection improved significantly more than the corticosteroid group, in terms of overall UCLA shoulder rating scale scores and passive abduction. VAS pain scores improved more in the NSAID group as well, but this difference did not reach significance.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
